Great saphenous vein transitory reflux in patients with symptoms related to chronic venous disorders, but without visible signs (C0s), and its correction with mpff treatment

Phlebolymphology

Volumn 22, Issue 1, 2015, Pages 18-24

  Tso Ukanov, Yu T ^a   Tso Ukanov, A Yu ^a   Nikolaychuk, A ^a  

^a Omsk State Pedagogic University   (Russian Federation)

Author keywords

Chronic venous disorders; Diagnosis; Great saphenous vein; Micronized purified flavonoid fraction; MPFF; Quality of life; Symptoms; Ultrasonography; Venous reflux

Indexed keywords

FLAVONOID; MICRONIZED PURIFIED FLAVONOID FRACTION; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CHRONIC VENOUS INSUFFICIENCY QUALITY OF LIFE QUESTIONNAIRE 20; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; DISEASE SEVERITY; DRUG EFFICACY; DUPLEX SCANNING; FEMALE; GLOBAL INDEX SCORE; HUMAN; LEG BLOOD FLOW; LEG COMPRESSION; LEG CRAMP; LEG DISEASE; LEG HEAVINESS; OPEN STUDY; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; SAPHENOUS VEIN TRANSITORY REFLUX; VEIN DIAMETER; VEIN DISEASE; VEIN INSUFFICIENCY; VENOUS REFLUX; VISUAL ANALOG SCALE;

EID: 84925212314     PISSN: 12860107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248-1252.
2. Guex JJ, Rabe E, Escotto SI, et al. The C0s patient: worldwide results from the Vein Consult Program. Phlebolymphology. 2012;19:182-192.
3. Andreozzi GM, Signorelli S, Di Pino L, et al. Varicose symptoms without varicose veins: the hypotonic phlebopathy, epidemiology and pathophysiology. The Acireale project. Minerva Cardioangiol. 2000;48:277-285.
4. Bergan JJ, Schmid-Schönbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006;355:488-498.
5. Schmid-Schönbein G. Inflammation and the pathophysiology of chronic venous insufficiency. Phlebolymphology. 2002;39:95-99.
6. Barwell JR, Davies CE, Deacon J, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomized controlled trial. Lancet. 2004;363:1854-1859.
7. Bogachev VYu. Hormone-induced phlebopathy. New problem of modern phlebology. Ang Vasc Surg. 2002;8(3):50-54.
8. Andreozzi GM. Prevalence of patients with chronic venous disease-related symptoms but without visible signs (described as C0s in the CEAP classification): the Italian experience. Phlebolymphology. 2006;13:28-35.
9. Vincent JR, Jones GT, Hill GB, van Rij AM. Failure of microvenous valves in small superficial veins is a key to the skin changes of venous insufficiency. J Vasc Surg. 2011;54:62S-69S.
10. Tsoukanov YuT. Local venous hypervolemia as a clinical pathophysiological phenomenon of varicose veins. Ang Vasc Surg. 2001;7:53-57.
11. Tsoukanov YuT, Tsoukanov AYu. Clinical assessment of phlebopathy severity by specification of leg heaviness symptom. Ang Vasc Surg. 2003;9:67-70.
12. Tsoukanov Yu T, Tsoukanov AYu, Bagenov VN. The effect of oral contraceptives on the orthostatic diameter of lower limb major veins and its correction. Ang Vasc Surg. 2008;14:75-77.
13. Nicolaides A, Kakkos S, Eklof B, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Int Angiol. 2014;33:126-139.
14. Pascarella L, Lulic D, Penn AH, et al. Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg. Eur J Vasc Endovasc Surg. 2008;35:102-110.
15. Lyseng-Williamson KA, Perry CM. Micronised purified flavonoid fraction. A review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs. 2003;63:71-100.
16. Labropoulos N. Cut point on normal and pathological values of reflux. Medicographia. 2008;30:157-162.
17. Schadeck M. Duplex scanning study of great saphenous veins in children: diameter, reflux and influence on therapy [in French]. Phlébologie. 1996;49:413-418.
18. Van Cleef JF, Hugentobler JP, Desvaux P, Griton P, Cloarec M. Endoscopic study of reflux of the saphenous valve [in French]. J Mal Vasc. 1992;17:113-116.
19. Gibson K, Meissner M, Wright D. Great saphenous vein diameter does not correlate with worsening quality of life scores in patients with great saphenous vein incompetence. J Vasc Surg. 2012;56:1634-1641.
20. Launois R, Mansilha A, Jantet G. International psychometric validation of the Chronic Venous Disease quality of life Questionnaire (CIVIQ-20). Eur J Vasc Endovasc Surg. 2010;40:783-789.
21. I begbuna V, Nicolaides AN, Sowade O, Leon M, Geroulakos G. Venous elasticity after treatment with Daflon 500 mg. Angiology. 1997;48:45.
22. Gargouil YM, Perdrix L, Chapelain B, Gaborieau R. Effects of Daflon 500 mg on bovine vessels contractility. Int Angiol. 1989;8:19-22.
23. Schultz-Ehrenburg U, Weindorf N, Matthes U, Hirche H. An epidemiologic study of the pathogenesis of varices. The Bochum study I-II [in French]. Phlébologie. 1992;45:497-500.
24. Criqui M, Denenberg JO, Bergan JJ, Langer RD, Fronek A. Risk factors for chronic venous disease: the San Diego population study. J Vasc Surg. 2007;46:331-337.
25. Boisseau MR. Chronic venous disease and the genetic influence. Phlebolymphology. 2014;21(2):100-111.
26. Mashiah A, Berman V, Thole HH, et al. Estrogen and progesterone receptors in normal and varicose saphenous veins. Cardiovasc Surg. 1999;7:327-331.
27. Bergan JJ. Venous valve incompetence: the first culprit in the pathophysiology of primary chronic venous insufficiency. Medicographia. 2008;30:87-90.
28. Asbeutah AM, Al-Enezi M, Al-Sharifi NM, et al. Changes in the diameter and valve closure time of leg veins across the menstrual cycle. J Ultrasound Med. 2014;33:803-809.
29. Schadeck M. Reflux in healthy valves of the great saphenous vein [in French]. Phlébologie. 1991;44:603-613.